Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Forbes Medi-Tech has received an opinion of substantial equivalence from European regulatory authorities allowing the company to market its cholesterol-lowering ingredient, Reducol, in seven major food groups.
Subscribe to our email newsletter
Reducol is now approved for marketing in food groups including margarine, fermented milk type products, soy drinks, low-fat cheese type products, yoghurt type products, spicy sauces, and salad dressings.
The substantial equivalence notification follows the recent approval for the use of Reducol in milk-based products.
With regulatory approvals in place and the recently announced expansion of the company’s 50-50 manufacturing joint-venture facility, biotech firm Forbes is now in a favorable position to capitalize on EU consumers’ preference for non-GMO foods.
“Our sales opportunities have increased significantly with the approval of Reducol in these key food groups,” said president and CEO, Charles Butt. “I am very encouraged by the level of enthusiasm of our European partners as they prepare for Reducol product launches in the coming months.”
Reducol helps to lower LDL (or ‘bad’) cholesterol levels safely and naturally and is produced by the Phyto-Source joint venture manufacturing facility in Pasadena, Texas.